Literaturnachweise: J Nutr. 2006 Jan;136(1 Suppl):295S-8S.Branched-chain amino acid enriched supplements as therapy for liver disease. Charlton M.Department of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA.
charlton.michael@mayo.edu
Clin Gastroenterol Hepatol. 2005 Jul;3(7):705-13.Effects of oral branched-chain amino acid granules on event-free survival in patients withliver cirrhosis.Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, Kato M, Nakamura T, Higuchi K, Nishiguchi S, Kumada H; Long-Term Survival Study Group.Gifu University, Gifu, Japan.
ichi-nai@cc.gifu-u.ac.jp
Hepatology. 2009 Nov;50(5):1360-9.Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.Freedman ND, Everhart JE, Lindsay KL, Ghany MG, Curto TM, Shiffman ML, Lee WM, Lok AS, Di Bisceglie AM, Bonkovsky HL, Hoefs JC,Dienstag JL, Morishima C, Abnet CC, Sinha R; HALT-C Trial Group. Gastroenterology. 2005 Dec;129(6):1928-36.Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States.Ruhl CE, Everhart JE.Social and Scientific Systems, Inc, Silver Spring, Maryland 20910, USA.
cruhl@s-3.com
World J Gastroenterol. 2011 Aug 7;17(29):3375-6.Nutritional recommendations for patients with non-alcoholic fatty liver diseases.Assy N.Liver Unit, Faculty of Medicine, Ziv Medical Center, Safed 13100, Israel.
assy.n@ziv.health.gov.il
Aliment Pharmacol Ther. 2010 Apr;31(7):679-92.Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fattyliver disease.Masterton GS, Plevris JN, Hayes PC.Department of Hepatology, Royal Infirmary of Edinburgh, Edinburgh, UK.
gailmasterton@hotmail.com
Biochim Biophys Acta. 2011 Oct 25.Fish oil - How does it reduce plasma triglycerides? Shearer GC, Savinova OV, Harris WS.Cardiovascular Health Research Center, Sanford Research USD, SD, USA; Sanford School of Medicine, University of South Dakota, SD, USA.
